Citius Oncology (CTOR) Change in Inventory (2024 - 2026)
Citius Oncology (CTOR) posted quarterly Change in Inventory of $20248.0 for Q1 2026, down 97.89% year-over-year from $957884.0 in Q1 2025, and down 94.26% quarter-over-quarter from $352649.0 in Q4 2025.
Citius Oncology (CTOR) Change in Inventory (2024 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Change in Inventory for 3 consecutive years, with $20248.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 97.89% year-over-year to $20248.0; the TTM figure through Mar 2026 stood at $6.0 million (changed N/A YoY), while the FY2025 annual figure was $12.6 million, up 492.78% from the prior year.
- Change in Inventory eased to $20248.0 in Q1 2026 per CTOR's latest filing, from $352649.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $6.1 million in Q4 2024 and bottomed at $20248.0 in Q1 2026.
- Historically, Change in Inventory has averaged $2.2 million across 3 years, with a median of $1.4 million in 2025.
- Annual changes were most pronounced in 2025 — Change in Inventory tumbled 94.23% — and 2026, when it tumbled 97.89%.
- Citius Oncology's Change in Inventory stood at $6.1 million in 2024, then tumbled by 94.23% to $352649.0 in 2025, then tumbled by 94.26% to $20248.0 in 2026.
- Business Quant data shows CTOR's Change in Inventory at $20248.0 in Q1 2026, $352649.0 in Q4 2025, and $3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Citius Oncology | 81.99 Mn | 81.99 Mn | 1.00 Mn | -33,645.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,248.00 |
| Mar 31, 2026 | 20,248.00 |
| Dec 31, 2025 | 352,649.00 |
| Dec 31, 2025 | 352,649.00 |
| Sep 30, 2025 | 3.71 Mn |
| Sep 30, 2025 | 3.71 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 957,884.00 |
| Mar 31, 2025 | 957,884.00 |
| Dec 31, 2024 | 6.11 Mn |
| Dec 31, 2024 | 6.11 Mn |